144 results
Page 3 of 8
424B3
mhyzwj5 yp
19 Jan 22
Prospectus supplement
4:05pm
8-K
EX-10.1
lndwlkziuuyaqem
14 Jun 21
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-99.2
r671c
6 May 21
Aravive continues to expand development of AVB-500 in multiple indications and combination treatments with first-line treatment for pancreatic cancer
7:08am
8-K
EX-99.2
9p7ygv
27 Apr 21
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant Ovarian Cancer
7:10am
424B5
8s8ujiewnt41x
16 Feb 21
Prospectus supplement for primary offering
7:05am
8-K
xvf 7pdhke2
4 Jan 21
Aravive Announces Board Member Transition to Advisory Role
4:11pm
8-K
EX-10.1
axqqpiaji1l
4 Jan 21
Aravive Announces Board Member Transition to Advisory Role
4:11pm